Features Screener Stocks Charts
Sign In Sign Up

Ajanta Pharma Limited Income Statement

NSE:AJANTPHARM | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year AJANTPHARM income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 42.93B 47.43B
Cost of Revenue -10.67B -10.71B
Gross Profit 32.27B 36.72B
Sales, General & Admin -19.70B -23.18B
Operating Income 11.21B 12.10B
Profit Before Tax 11.14B 11.89B
Net Income 8.16B 9.20B
Diluted Shares 126.01M 125.17M
Diluted EPS 64.77 73.53

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025